[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 25, Issue 1 (2-2021) ::
__Armaghane Danesh__ 2021, 25(1): 40-54 Back to browse issues page
Synthesis of Pirano-Based Piranazole-based Compounds to Induce Apoptosis by Reducing the Expression of Anti-Apoptotic Protein B2 Cell Lymphoma Protein in the MCF-7 Human Breast Cancer Cell Category
H Shahriyari-Nejad1, N Pourmohsen1, H Ghafouri 2, S Zareie1, R Sharifi3, N Mahmoodi3
1- Department of Biology, University of Guilan, Rasht, Iran
2- Department of Biology, University of Guilan, Rasht, Iran , h.ghafoori@guilan.ac.ir
3- Department of Chemistry, University of Guilan, Rasht, Iran
Abstract:   (1320 Views)
Background & aim: B-cell lymphoma 2 (Bcl-2) is a potential target for tumor treatment. The inhibition of the Bcl-2 production is research target of attraction in the field of anti-cancer drug development. The present study aimed to evaluate the inhibitory effects of novel pyrazole derivatives on Bcl-2 expression in human breast cancer cell line MCF-7.
 
Methods: In the present in vitro experimental study, the newly synthesized substances were screened against breast Aden carcinoma (MCF-7). The Western-blot analysis was carried out to study signaling pathways of MCF-7 breast cancer cells. The levels of apoptosis-related protein (Bcl-2) were evaluated by western blot analysis and changes in it expression were confirmed. Data were analyzed using one-way ANOVA, and independent t-test.
 
Results: The compounds HN1 and HN2 significantly inhibited the proliferation of human breast cancer cells. The compounds HN1and HN2 inhibited the growth of MCF-7 cells with IC50 values of 7.4 μg/ml and 8.68 μg/ml, respectively. In addition, compounds HN1and HN2 (22.5-50 μg/ml) significantly inhibited the anti-apoptotic Bcl-2 protein production. The compound HN2 significantly inhibited Bcl-2 expression in a concentration-dependent manner, corresponding 24% at 37.5 μg/ml, 30% at 50 μg/ml. Also compound HN1 at the same concentrations inhibited Bcl-2 expression by 12%, 0% at 50 and 37/5 μg/ml in MCF-7 cells, respectively.
 
Conclusion: HN2 could suppress the viability of MCF-7 cells and induce apoptosis in breast cancer cells by down-regulation of anti-apoptotic factor, Bcl-2. These results revealed that the potential inhibitory effect of HN2 against growth of MCF-7 human breast cancer cells might be associated with induction of apoptosis through Bcl-2 protein dependent pathway. The present results suggest that HN2 has a promising potential to be used as a valuable chemo preventive agent.
 
 
Keywords: Pyrazole, Apoptosis, MCF-7 cells, Bcl-2
Full-Text [PDF 2076 kb]   (16 Downloads)    
Type of Study: Research | Subject: Biochemistry
Received: 2019/08/17 | Accepted: 2019/12/2 | Published: 2020/03/4
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shahriyari-Nejad H, Pourmohsen N, Ghafouri H, Zareie S, Sharifi R, Mahmoodi N. Synthesis of Pirano-Based Piranazole-based Compounds to Induce Apoptosis by Reducing the Expression of Anti-Apoptotic Protein B2 Cell Lymphoma Protein in the MCF-7 Human Breast Cancer Cell Category. Armaghane danesh. 2021; 25 (1) :40-54
URL: http://armaghanj.yums.ac.ir/article-1-2598-en.html


Volume 25, Issue 1 (2-2021) Back to browse issues page
ارمغان دانش Armaghane danesh
Persian site map - English site map - Created in 0.07 seconds with 32 queries by YEKTAWEB 4106